| 摘要 |
FIELD: medicine. ^ SUBSTANCE: what is described is a composition for fistula treatment in an individual, including stromal stem cells of fatty tissue where at least approximately 50 % of stromal stem cells of fatty tissue making a composition, express CD9, CD10, CD13, CD29, CD44, CD49A, CD51, CD54, CD55, CD58, CD59, CD90 and CD105 markers and where the contents of the stromal stem cells of fatty tissue in the composition makes at least approximately 3ù106 cells/ml. ^ EFFECT: invention extends the range of products for fistula treatment. ^ 8 cl, 7 dwg, 4 ex |
